Epidemiology
≈ 11 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Epidemiology is the study and analysis of the distribution (who, when, and where), patterns and determinants of health and disease conditions in a defined population, and application of this knowledge to prevent diseases. It is a cornerstone of public health, and shapes policy decisions and evidence-based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, collection, and statistical analysis of data, amend interpretation and dissemination of results (including peer review and occasional systematic review). Epidemiology has helped develop methodology used in clinical research, public health studies, and, to a lesser extent, basic research in the biological sciences. Major areas of epidemiological study include disease causation, transmission, outbreak investigation, disease surveillance, environmental epidemiology, forensic epidemiology, occupational epidemiology, screening, biomonitoring, and comparisons of treatment effects such as in clinical trials. Epidemiologists rely on other scientific disciplines like biology to better understand disease processes, statistics to make efficient use of the data and draw appropriate conclusions, social sciences to better understand proximate and distal causes, and engineering for exposure assessment.…
Epidemiology is the study and analysis of the distribution (who, when, and where), patterns and determinants of health and disease conditions in a defined population, and application of this knowledge to prevent diseases. It is a cornerstone of public health, and shapes policy decisions and evidence-based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, collection, and statistical analysis of data, amend interpretation and dissemination of results (including peer review and occasional systematic review). Epidemiology has helped develop methodology used in clinical research, public health studies, and, to a lesser extent, basic research in the biological sciences. Major areas of epidemiological study include disease causation, transmission, outbreak investigation, disease surveillance, environmental epidemiology, forensic epidemiology, occupational epidemiology, screening, biomonitoring, and comparisons of treatment effects such as in clinical trials. Epidemiologists rely on other scientific disciplines like biology to better understand disease processes, statistics to make efficient use of the data and draw appropriate conclusions, social sciences to better understand proximate and distal causes, and engineering for exposure assessment. Epidemiology, literally meaning 'the study of what is upon the people', is derived , referring to the study of human populations. However, the term is widely used in studies of zoological populations (veterinary epidemiology), although the term 'epizootiology' was historically used. 'Epidemiology' has also been applied to studies of plant populations (botanical or plant disease epidemiology). The distinction between "epidemic" and "endemic" was first drawn by Hippocrates, The term "epidemiology" appears to have first been used to describe the study of epidemics in 1802 by the Spanish physician in Epidemiología Española. Epidemiologists also study the interaction of diseases in a population, a condition known as a syndemic. The term epidemiology is now widely applied to cover the description and causation of not only epidemic, infectious disease, but of disease in general, including related conditions and, especially since the 20th century, chronic diseases such as diabetes, cardiovascular disease, and cancer. Some examples of topics examined through epidemiology include high blood pressure, mental illness and obesity. Therefore, this epidemiology is based upon how the pattern of the disease causes change in the function of human beings. Case-control studies select subjects based on their disease status. It is a retrospective study. A group of individuals that are disease positive (the "case" group) is compared with a group of disease negative individuals (the "control" group). The control group should ideally come from the same population that gave rise to the cases. The case-control study looks back through time at potential exposures that both groups (cases and controls) may have encountered. A 2×2 table is constructed, displaying exposed cases (A), exposed controls (B), unexposed cases (C) and unexposed controls (D). The statistic generated to measure association is the odds ratio (OR), which is the ratio of the odds of exposure in the cases (A/C) to the odds of exposure in the controls (B/D), i.e. OR = (AD/BC). If the OR is significantly greater than 1, then the conclusion is "those with the disease are more likely to have been exposed", whereas if it is close to 1 then the exposure and disease are not likely associated. If the OR is far less than one, then this suggests that the exposure is a protective factor in the causation of the disease. Case-control studies are usually faster and more cost-effective than cohort studies but are sensitive to bias (such as recall bias and selection bias). The main challenge is to identify the appropriate control group; the distribution of exposure among the control group should be representative of the distribution in the population that gave rise to the cases. This can be achieved by drawing a random sample from the original population at risk. This has as a consequence that the control group can contain people with the disease under study when the disease has a high attack rate in a population. A major drawback for case control studies is that, in order to be considered to be statistically significant, the minimum number of cases required at the 95% confidence interval is related to the odds ratio by the equation: \text{total cases} = A+C = 1.96^2 (1+N) \left(\frac{1}{\ln(OR)}\right)^2 \left(\frac{OR+2\sqrt{OR}+1}{\sqrt{OR}}\right) \approx 15.5 (1+N) \left(\frac{1}{\ln(OR)}\right)^2 where N is the ratio of cases to controls. As the odds ratio approaches 1, the number of cases required for statistical significance grows towards infinity; rendering case-control studies all but useless for low odds ratios. For instance, for an odds ratio of 1.5 and cases = controls, the table shown above would look like this: For an odds ratio of 1.1: Cohort studies select subjects based on their exposure status. The study subjects should be at risk of the outcome under investigation at the beginning of the cohort study; this usually means that they should be disease free when the cohort study starts. The cohort is followed through time to assess their later outcome status. An example of a cohort study would be the investigation of a cohort of smokers and non-smokers over time to estimate the incidence of lung cancer. The same 2×2 table is constructed as with the case control study. However, the point estimate generated is the relative risk (RR), which is the probability of disease for a person in the exposed group, P e = A / (A + B) over the probability of disease for a person in the unexposed group, P u = C / (C + D), i.e. RR = P e / P u . As with the OR, a RR greater than 1 shows association, where the conclusion can be read "those with the exposure were more likely to develop the disease." Prospective studies have many benefits over case control studies. The RR is a more powerful effect measure than the OR, as the OR is just an estimation of the RR, since true incidence cannot be calculated in a case control study where subjects are selected based on disease status. Temporality can be established in a prospective study, and confounders are more easily controlled for. However, they are more costly, and there is a greater chance of losing subjects to follow-up based on the long time period over which the cohort is followed. Cohort studies also are limited by the same equation for number of cases as for cohort studies, but, if the base incidence rate in the study population is very low, the number of cases required is reduced by .
Epidemic wave
The concept of waves in epidemics has implications especially for communicable diseases. A working definition for the term "epidemic wave" is based on two key features: 1) it comprises periods of upward or downward trends, and 2) these increases or decreases must be substantial and sustained over a period of time, in order to distinguish them from minor fluctuations or reporting errors. The use of a consistent scientific definition is to provide a consistent language that can be used to communicate about and understand the progression of the COVID-19 pandemic, which would aid healthcare organizations and policymakers in resource planning and allocation.
Validities
Different fields in epidemiology have different levels of validity. One way to assess the validity of findings is the ratio of false-positives (claimed effects that are not correct) to false-negatives (studies which fail to support a true effect). In genetic epidemiology, candidate-gene studies may produce over 100 false-positive findings for each false-negative. By contrast genome-wide association appear close to the reverse, with only one false positive for every 100 or more false-negatives. This ratio has improved over time in genetic epidemiology, as the field has adopted stringent criteria. By contrast, other epidemiological fields have not required such rigorous reporting and are much less reliable as a result. Confounding has traditionally been defined as bias arising from the co-occurrence or mixing of effects of extraneous factors, referred to as confounders, with the main effect(s) of interest. A more recent definition of confounding invokes the notion of counterfactual effects. According to this view, when one observes an outcome of interest, say Y=1 (as opposed to Y=0), in a given population A which is entirely exposed (i.e. exposure X = 1 for every unit of the population) the risk of this event will be R A1 . The counterfactual or unobserved risk R A0 corresponds to the risk which would have been observed if these same individuals had been unexposed (i.e. X = 0 for every unit of the population). The true effect of exposure therefore is: R A1 − R A0 (if one is interested in risk differences) or R A1 /R A0 (if one is interested in relative risk). Since the counterfactual risk R A0 is unobservable we approximate it using a second population B and we actually measure the following relations: R A1 − R B0 or R A1 /R B0 . In this situation, confounding occurs when R A0 ≠ R B0 . (NB: Example assumes binary outcome and exposure variables.) Some epidemiologists prefer to think of confounding separately from common categorizations of bias since, unlike selection and information bias, confounding stems from real causal effects.
COVID-19
An April 2020 University of Southern California article noted that, "The coronavirus epidemic... thrust epidemiology – the study of the incidence, distribution and control of disease in a population – to the forefront of scientific disciplines across the globe and even made temporary celebrities out of some of its practitioners." Miquel Porta, editor (2014) "A dictionary of epidemiology", 6th edn, New York: Oxford University Press. A Dictionary of Epidemiology Morabia, Alfredo, editor. (2004) A History of Epidemiologic Methods and Concepts. Basel, Birkhauser Verlag. Part I. A History of Epidemiologic Methods and Concepts A History of Epidemiologic Methods and Concepts Smetanin P, Kobak P, Moyer C, Maley O (2005). "The Risk Management of Tobacco Control Research Policy Programs" The World Conference on Tobacco OR Health Conference, 12–15 July 2006, Washington DC. Szklo M, Nieto FJ (2002). "Epidemiology: beyond the basics", Aspen Publishers. Robertson LS (2015). Injury Epidemiology: Fourth Edition. Free online at nanlee.net Rothman K., Sander Greenland, Lash T., editors (2008). "Modern Epidemiology", 3rd Edition, Lippincott Williams & Wilkins. Olsen J, Christensen K, Murray J, Ekbom A. An Introduction to Epidemiology for Health Professionals. New York: Springer Science+Business Media; 2010
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372526339 under CC BY-SA 4.0; modifications have been made.